NewswireToday - /newswire/ -
Philadelphia, PA, United States, 2010/10/27 - CIS, a pharmaceutical compliance consulting firm, announced that Judy Fox, CIS Director for U.S. Global Compliance, has been re-elected to a three-year term on the PDMA Alliance Inc. Board of Directors.
Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that Judy Fox, CIS Director for U.S. Global Compliance, has been re-elected to a three-year term on the PDMA Alliance Inc. Board of Directors.
Beginning as the pharmaceutical industry’s focal point for learning, exchanging ideas, and networking on issues related to the Prescription Drug Marketing Act (PDMA) compliance, the Alliance recognized changes in the industry and expanded its reach to include commercial compliance concerns facing its members.
"I am honored and excited to continue serving as a member of the Alliance Board of Directors,” said Fox. "It is a tremendous vote of confidence that the membership has given me the opportunity to continuing working with them as we pursue solutions to address the issues that affect the entire industry."
In addition to acting as an industry resource, Ms. Fox and other members of the Board are responsible for ensuring that content and speakers for the upcoming 2011 PDMA Sharing Conference meet membership needs and expectations. The annual conference is a meeting of compliance professionals who benefit from the expertise of law enforcement and industry leaders, review new compliance products and services, and share in informal communications with their colleagues and business partners.
In the past ten years, Ms. Fox has amassed diverse experience in the pharmaceutical industry in the areas of compliance, regulatory affairs, commercial operations, quality assurance, and inventory management. Ms. Fox currently leads CIS’ PDMA and State Reporting service offerings.
Compliance Implementation Services (CIS) is a consulting firm specializing in compliance strategies for the pharmaceutical industry, from Global Clinical Research and Development, through Manufacturing, U.S. Commercial Compliance, and Government Programs. Founded in 2004, CIS (cis-partners.com) provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to establish a “Culture of Compliance” that is both meaningful and sustainable.
CIS experts identify, assess and prioritize an organization’s exposure to compliance risks, subsequently developing and implementing risk evaluation and mitigation techniques to ensure adherence to legal and regulatory requirements.
About The PDMA Alliance
The PDMA Alliance, Inc. (pdmaalliance.org) is the industry voice of PDMA compliance professionals. Its members are dedicated to improving the understanding of the PDMA by the pharmaceutical industry, and to strengthening the efficiency and effectiveness of the sample accountability programs administered by its members. The Alliance serves as the industry’s focal point for learning, exchanging ideas, and networking on issues related to PDMA compliance. The organization works closely with the U.S. Food and Drug Administration (FDA), and with its members, to continually improve business and security practices.